Oppenheimer & Co’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
80,471
-31,365
| -28% | -$447K | 0.02% | 794 |
|
|
2025
Q1 | $1.67M | Sell |
111,836
-2,024
| -2% | -$30.2K | 0.03% | 595 |
|
|
2024
Q4 | $1.64M | Sell |
113,860
-90,494
| -44% | -$1.3M | 0.02% | 606 |
|
|
2024
Q3 | $3.24M | Buy |
204,354
+1,153
| +0.6% | +$18.3K | 0.05% | 396 |
|
|
2024
Q2 | $3.12M | Buy |
203,201
+57,933
| +40% | +$890K | 0.05% | 392 |
|
|
2024
Q1 | $2.38M | Buy |
145,268
+68,569
| +89% | +$1.12M | 0.04% | 462 |
|
|
2023
Q4 | $1.12M | Buy |
76,699
+1,536
| +2% | +$22.5K | 0.02% | 667 |
|
|
2023
Q3 | $1.08M | Buy |
75,163
+9,082
| +14% | +$131K | 0.02% | 647 |
|
|
2023
Q2 | $1.09M | Buy |
66,081
+21,815
| +49% | +$358K | 0.02% | 675 |
|
|
2023
Q1 | $740K | Buy |
44,266
+4,263
| +11% | +$71.2K | 0.02% | 803 |
|
|
2022
Q4 | $617K | Buy |
40,003
+31
| +0.1% | +$478 | 0.01% | 852 |
|
|
2022
Q3 | $597K | Buy |
39,972
+4,395
| +12% | +$65.6K | 0.01% | 829 |
|
|
2022
Q2 | $585K | Sell |
35,577
-1,066
| -3% | -$17.5K | 0.01% | 862 |
|
|
2022
Q1 | $735K | Buy |
36,643
+3,519
| +11% | +$70.6K | 0.01% | 861 |
|
|
2021
Q4 | $840K | Buy |
33,124
+6,588
| +25% | +$167K | 0.01% | 850 |
|
|
2021
Q3 | $716K | Buy |
26,536
+181
| +0.7% | +$4.88K | 0.01% | 869 |
|
|
2021
Q2 | $762K | Buy |
26,355
+189
| +0.7% | +$5.47K | 0.01% | 854 |
|
|
2021
Q1 | $688K | Buy |
26,166
+4,986
| +24% | +$131K | 0.01% | 838 |
|
|
2020
Q4 | $607K | Buy |
21,180
+1,023
| +5% | +$29.3K | 0.01% | 818 |
|
|
2020
Q3 | $481K | Buy |
20,157
+1,437
| +8% | +$34.3K | 0.01% | 815 |
|
|
2020
Q2 | $391K | Buy |
+18,720
| New | +$391K | 0.01% | 882 |
|